Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack

Belfast Health and Social Care Trust

This public procurement record has 2 releases in its history.

Award

08 Sep 2026 at 10:32

UK6 - Contract Award Notice
Award

07 Sep 2026 at 13:39

UK5 - Transparency Notice
Summary of the contracting process

Belfast Health & Social Care Trust is procuring secukinumab 300 mg pre-filled injection pens, supplied as one-pen packs. This is a pharmaceutical goods requirement for essential patient care. The named supplier is Novartis Pharmaceuticals UK Limited, a large pharmaceutical company based in London. Delivery is within the United Kingdom. The procurement covers one completed lot and concerns a specific branded medicine rather than a general medicines supply or a clinical service. Businesses with relevant pharmaceutical manufacturing, licensing, distribution or specialist medicines supply capabilities would need to assess whether they can provide this exact product and meet the Trust’s patient-care requirements.

The procurement has been awarded through a direct award, with Novartis Pharmaceuticals UK Limited selected as supplier for the completed lot. The award date was 8 September 2026, with a value of £280,000 including tax. The award is above the relevant threshold. The contract period runs from 19 September 2026 to 30 September 2028, and the scheduled signature date is 19 September 2026. A standstill period ends on 18 September 2026. The Trust’s rationale is that the medicine is branded and patent-protected, essential to patient care, and available from only one economic operator; the absence of competition was not caused by artificially narrowing the requirement. The published classification identifies exclusive intellectual-property rights and a single supplier.

This award indicates established demand from Belfast Health & Social Care Trust for a named, patent-protected pharmaceutical product used in essential patient care. The successful supplier profile is a large specialist pharmaceutical business able to provide secukinumab in the specified 300 mg pre-filled pen presentation and support supply of a regulated medicine. A future competitor would need credible rights or authorisation to supply the exact branded product, dependable pharmaceutical distribution, and the operational capacity to maintain continuity of patient treatment. Relevant evidence would include experience supplying NHS or comparable healthcare organisations, robust medicines quality and traceability arrangements, and the ability to meet the Trust’s ordering and delivery requirements. General medicines capability alone would not address this narrowly defined requirement.

How relevant is this notice?

Notice Information

Notice Title

SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack

Notice Description

Procurement of SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack

Procurement Information

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06f385
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/084749-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£280,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
8 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
8 Sep 20261 weeks ago
Contract Period
19 Sep 2026 - 30 Sep 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Belfast Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BELFAST
Postcode
BT12 6BA
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN06 Belfast
Delivery Location
Not specified
Local Authority
Belfast
Electoral Ward
Falls
Westminster Constituency
Belfast West

Supplier Information

Number of Suppliers
1
Supplier Name

Novartis Pharmaceuticals UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...